New Study of a Novel Metabolic Procedure with Self-Assembling Magnets for Obese Patients with Type 2 Diabetes deemed safe and feasible. 

U.S. FDA Grants GI Windows Medical Corp, Breakthrough Device Designation for Magnetic Anastomosis Technology

GI Windows featured in JJDC 2020 Annual Newsletter highlighting it's investment in GI Windows

GI Windows Corp, a clinical-stage, privately-held medical device company, announced a $16.4 million Series A-1.  The financing attracted Johnson & Johnson Innovation - JJDC, along with Sonder Capital, GT Healthcare, JC Investco and one additional strategic investo

GI Windows Named Winner of Emerging MedTech Company of the Year

GI Windows Corp, a clinical-stage, privately-held medical device company, announced a $14.6 million Series A financing